Document Detail


Isoflavone agonists of IRF-3 dependent signaling have antiviral activity against RNA viruses.
MedLine Citation:
PMID:  22532686     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
There is a growing need for novel antiviral therapies that are broad spectrum, effective, and not subject to resistance due to viral mutations. Using high-throughput screening methods, including computational docking studies and an interferon-stimulated gene 54 (ISG54)-luciferase reporter assay, we identified a class of isoflavone compounds that act as specific agonists of innate immune signaling pathways and cause activation of the interferon regulatory factor (IRF-3) transcription factor. The isoflavone compounds activated the ISG54 promoter, mediated nuclear translocation of IRF-3, and displayed highly potent activity against hepatitis C virus (HCV) and influenza virus. Additionally, these agonists efficiently activated IRF-3 in the presence of the HCV protease NS3-4A, which is known to blunt the host immune response. Furthermore, genomic studies showed that discrete innate immune pathways centered on IRF signaling were regulated following agonist treatment without causing global changes in host gene expression. Following treatment, the expression of only 64 cellular genes was significantly induced. This report provides the first evidence that innate immune pathways dependent on IRF-3 can be successfully targeted by small-molecule drugs for the development of novel broad-spectrum antiviral compounds.
Authors:
Kristin M Bedard; Myra L Wang; Sean C Proll; Yueh-Ming Loo; Michael G Katze; Michael Gale; Shawn P Iadonato
Related Documents :
22498476 - Atg5, autophagy and lung function in asthma.
17367766 - Low-frequency electroacupuncture suppresses zymosan-induced peripheral inflammation via...
22634606 - The wap protein trappin-2/elafin: a handyman in the regulation of inflammatory and immu...
22809086 - New tricks for metastasis-associated macrophages.
20039306 - Does tlr2 regulate intestinal inflammation?
18200516 - Vitamin d derivatives induce apoptosis and downregulate icam-1 levels in peripheral blo...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural     Date:  2012-04-24
Journal Detail:
Title:  Journal of virology     Volume:  86     ISSN:  1098-5514     ISO Abbreviation:  J. Virol.     Publication Date:  2012 Jul 
Date Detail:
Created Date:  2012-06-08     Completed Date:  2012-08-15     Revised Date:  2013-05-20    
Medline Journal Info:
Nlm Unique ID:  0113724     Medline TA:  J Virol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  7334-44     Citation Subset:  IM    
Affiliation:
Kineta, Inc., Seattle, Washington, USA. kbedard@kineta.us
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antiviral Agents / metabolism*
Hepacivirus / immunology*,  physiology
Humans
Immunity, Innate
Immunologic Factors / metabolism*
Interferon Regulatory Factor-3 / biosynthesis*
Isoflavones / agonists*
Orthomyxoviridae / immunology*,  physiology
Protein Transport
Signal Transduction / drug effects*
Virus Replication
Grant Support
ID/Acronym/Agency:
HSSN 272200900035C//PHS HHS; R43AI081335/AI/NIAID NIH HHS; R44 AI081335/AI/NIAID NIH HHS
Chemical
Reg. No./Substance:
0/Antiviral Agents; 0/IRF3 protein, human; 0/Immunologic Factors; 0/Interferon Regulatory Factor-3; 0/Isoflavones
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The IE180 protein of pseudorabies virus suppresses phosphorylation of translation initiation factor ...
Next Document:  Inhibition of interferon regulatory factor 3 activation by paramyxovirus V protein.